NCT07647614: A Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for Parkinson's Disease
- State
- Not started
- Phase
- Phase 2
- People
- 105 planned
- Started
- 1 Dec 2026
- Primary completion
- 1 Jan 2030
- Arms
- Low-dose ENERGI-F705 Tablets
- Results
- None posted
- 15 Jun 2026: Trial registered